Skip to Content

Rule

New Animal Drugs; Change of Sponsor's Name and Address; Corrections

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Correcting amendments.

SUMMARY:

The Food and Drug Administration (FDA) published a document in the Federal Register of April 20, 2010 (75 FR 20522) amending the animal drug regulations to reflect changes to a sponsor's name and address. That document contained errors in the regulatory text. FDA is correcting the tables listing sponsors of approved animal drug applications (NADAs) by adding a change to the sponsor's drug labeler code (DLC). Cross-references to the sponsor's DLC are amended in two sections of the Code of Federal Regulations (CFR) containing the conditions of use approved animal drug products. These corrections are being made to improve the accuracy of the animal drug regulations.

DATES:

This rule is effective March 24, 2011.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-276-9019, e-mail: george.haibel@fda.hhs.gov.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Food and Drug Administration (FDA) published a document in the Federal Register of April 20, 2010 (75 FR 20522) amending the animal drug regulations to reflect changes to a sponsor's name and address. That document contained errors in the regulatory text. FDA is correcting the tables listing sponsors of approved animal drug applications (NADAs) by adding a change to the sponsor's drug labeler code (DLC). Cross-references to the sponsor's DLC are amended in two sections of the Code of Federal Regulations (CFR) containing the conditions of use approved animal drug products. These corrections are being made to improve the accuracy of the animal drug regulations.

Start List of Subjects

List of Subjects

End List of Subjects

Accordingly, 21 CFR parts 510 and 529 are corrected by making the following correcting amendments:

Start Part

PART 510—NEW ANIMAL DRUGS

End Part Start Amendment Part

1. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

End Authority Start Amendment Part

2. In § 510.600, in the table in paragraph (c)(1), revise the entry for “Piramal Critical Care, Inc.”; and in the table in paragraph (c)(2), remove the

End Amendment Part
Names, addresses, and drug labeler codes of sponsors of approved applications.
* * * * *

(c) * * *

(1) * * *

Firm name and addressDrug labeler code
*    *    *    *    *
Piramal Critical Care, Inc., 3850 Schelden Circle, Bethlehem, PA 18017066794
*    *    *    *    *

(2) * * *

Drug labeler codeFirm name and address
*    *    *    *    *
066794Piramal Critical Care, Inc., 3850 Schelden Circle, Bethlehem, PA 18017.
*    *    *    *    *
Start Part

PART 529—CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS

End Part Start Amendment Part

3. The authority citation for

End Amendment Part Start Authority

Authority: 21 U.S.C. 360b.

End Authority
[Corrected]
Start Amendment Part

4. In paragraph (b) of § 529.1186, remove “060307, and 065085” and in its place add “065085, and 066794”.

End Amendment Part
[Corrected]
Start Amendment Part

5. In paragraph (b) of § 529.2150, remove “060307” and in its place add “066794”.

End Amendment Part Start Signature

Dated: March 17, 2011.

Leslie Kux,

Acting Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2011-6795 Filed 3-23-11; 8:45 am]

BILLING CODE 4160-01-P